Testosterone replacement therapy and prostate cancer: A word of caution

被引：19
|
作者：
Brand T.C. [1 ]
Canby-Hagino E. [1 ]
Thompson I.M. [1 ]
机构：
[1] Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229
来源：
Current Urology Reports | 2007年 / 8卷 / 3期
关键词：
Prostate Cancer; Testosterone; Digital Rectal Examination; Free Testosterone; Prostatic Intraepithelial Neoplasia;
D O I：
10.1007/s11934-007-0004-x
中图分类号：
学科分类号：
摘要：
The number of men for whom testosterone is prescribed is rapidly Increasing. The aging man normally demonstrates a gradual decline in testosterone. Symptoms of hypogonadism include erectile dysfunction, diminished libido, sarcopenia, increased adiposity, osteopenia and osteoporosis, impaired cognition, and depression. There is a paucity of data regarding both efficacy and safety of testosterone replacement therapy. Testosterone levels have been shown to modulate prostate cancer risk and progression. A prospective evaluation of prostate cancer risk with testosterone replacement therapy has not been conducted. We outline concerns and recommendations for the use of testosterone replacement therapy in the aging man. Copyright © 2007 by Current Medicine Croup LLC.
引用
收藏
页码：185 / 189
页数：4
相关论文
共 50 条
  • [41] TESTOSTERONE REPLACEMENT THERAPY IN PATIENTS WITH A DIAGNOSIS OF PROSTATE CANCER: FACT OR FICTION?
    Nehra, Ajay
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 98 - 98
  • [42] TESTOSTERONE REPLACEMENT THERAPY IN MEN UNDERGOING ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Berookhim, B.
    Krishnan, R.
    Nelson, C.
    Mulhall, J. P.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 13 - 13
  • [43] The role of testosterone replacement therapy and statin use, and their combination, in prostate cancer
    Lopez, David S.
    Huang, Danmeng
    Tsilidis, Konstantinos K.
    Canfield, Steven
    Khera, Mohit
    Baillargeon, Jacques G.
    Kuo, Yong-Fang
    Peek, M. Kristen
    Platz, Elizabeth A.
    Markides, Kyriakos
    CANCER CAUSES & CONTROL, 2021, 32 (09) : 965 - 976
  • [44] Impact of testosterone replacement therapy after radiation therapy on prostate cancer outcomes.
    Sarkar, Reith
    Parsons, J. Kellogg
    Einck, John Paul
    Mundt, Arno James
    Kader, A. Karim
    Kane, Christopher J.
    Riviere, Paul
    Mckay, Rana R.
    Murphy, James Don
    Rose, Brent Shane
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [45] The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy
    Xie, Tao
    Song, Xian-Lu
    Wang, Chong
    Yu, Yu-Zhong
    Wang, Jing-Quan
    Chen, Zhe-Sheng
    Zhao, Shan-Chao
    DRUG DISCOVERY TODAY, 2021, 26 (05) : 1293 - 1301
  • [46] Prostate and cardiac safety in testosterone replacement therapy
    Saad, F.
    JOURNAL OF MENS HEALTH, 2011, 8 : S100 - S101
  • [47] TESTOSTERONE THERAPY AND PROSTATE CANCER
    Suer, Ender
    Yaman, Onder
    TURKISH JOURNAL OF UROLOGY, 2008, 34 (01): : 27 - 30
  • [48] Testosterone therapy and prostate cancer
    Pastuszak, Alexander W.
    Rodriguez, Katherine M.
    Nguyen, Taylor M.
    Khera, Mohit
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2016, 5 (06) : 909 - 920
  • [49] Testosterone Therapy and Prostate Cancer
    Davidson, Emily
    Morgentaler, Abraham
    UROLOGIC CLINICS OF NORTH AMERICA, 2016, 43 (02) : 209 - +
  • [50] TESTOSTERONE REPLACEMENT THERAPY IN HYPOGONADAL MEN UNDERGOING ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Berookhim, B.
    Krishnan, R.
    Nelson, C. J.
    Mulhall, J. P.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 147 - 148
12345